Business
Applied BioSciences Announces Record Revenue
Applied BioSciences Announces Record Revenue.
About this update from Applied Biosciences Corp.
[{"type":"text","content":"\nLOS ANGELES, March 18, 2019 (GLOBE NEWSWIRE) -- Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on the medical, bioceutical, testing and analytics and pet health industries, announced that it has achieved a record revenue quarter with multiple milestones. The company has made strategic investments in select brands and companies believed to be innovators in the consumer space.  The investment remains on the balance sheet under Equity Investments, but the company has begun a strategic review of options for the remaining equity stake.\n Q3 2019 Financial and Operating Highlights Q3 Revenue for the Company was $413,109, a 560% increase from Q3 2018 and a 744% increase from the previous quarterLaunched multiple new products and has expanded into the Beverage and Health / Wellness category with Remedi Spa and Remedi Beverage and ShotStarted initial Pharmacokinetic Safety Study with a leading firm in the Pet spaceBegun discussions regarding Scientific Trials with two leading Universities specializing in Veterinarian Medicine “Applied BioSciences results in the third quarter mark a solid acceleration to a historical year in a dynamic and rapidly evolving space.  We look forward to updating the investor community on our milestones and continued progress.”  stated Chris Bridges, President of Applied BioSciences Corp. Subsequent to Q3 2019 Received a $186,000 distribution from its investment in Juul Labs, Inc.Announced the acquisition of Trace Analytics with over 65 years of combined experience in the the global testing market for Cannabis and HempAdded 3 PhDs and 5 scientists to its operational teamLaunch the first Organic Human Quality Pet Treats under the HerbalPet brandAdded Dr. Xiang-Qun (Sean) Xie to its Scientific Advisory Board. Dr. Xie who has over 30 years of experience in the fields of Genomics, Cancer Research and has multiple patents that have been licensed to BioTech and Pharmaceutical companies.  “Applied BioSciences continues to be at the forefront of the evolving consumer and testing market, using organically grown plants, without pesticides or herbicides as our main ingredient.  As the company, continues to expand our product lines it is important to know that our products have been thoroughly tested by trusted labs in the industr...